ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT07144111 updates: 1. completion date: 2026-09-09 → 2026-09-06 2. primary completion date: 2026-09-05 → 2026-09-04
Clinical trial NCT07144111 updates: 1. completion date: 2026-09-09 → 2026-09-06 2. primary completion date: 2026-09-05 → 2026-09-04
Clinical trial NCT05670106 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-04-22
Clinical trial NCT00419380: enrollment: 40 → 41 participants.
Clinical trial NCT06949644 updates: 1. completion date: 2029-07-31 → 2029-08-31 2. primary completion date: 2029-02-28 → 2029-07-31
Clinical trial NCT07582328 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-07 → 2026-05-28 3. primary completion date: 2026-08-07 → 2026-05-28 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07322341: start date: 2026-06-01 → 2026-09-01.
Clinical trial NCT07584434 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-12 → 2026-05-21
Clinical trial NCT06693908: primary completion date: 2026-06-09 → 2026-07-09.
Clinical trial NCT05741658: primary completion date: 2026-04-01 → 2026-06-01.
Clinical trial NCT05651932: enrollment: 125 → 165 participants.